Discontinuation report NOVORAPID

Last updated on 2023-08-17 History
Report ID 182889
Drug Identification Number 02377209
Brand name NOVORAPID
Common or Proper name NOVORAPID FLEXTOUCH 100U 5X3ML
Company Name NOVO NORDISK CANADA INC
Market Status CANCELLED POST MARKET
Active Ingredient(s) INSULIN ASPART
Strength(s) 100UNIT
Dosage form(s) SOLUTION
Route of administration SUBCUTANEOUS SUBCUTANEOUS
Packaging size EA
ATC code A10AB
ATC description INSULINS AND ANALOGUES
Reason for discontinuation Business reasons
Anticipated discontinuation date 2023-08-31
Actual discontinuation date 2023-08-16
Remaining supply date 2023-07-31
Discontinuation status Discontinued
Discontinuation decision reversal No
Information on remaining supply
Company comments Patients who continue to have coverage for NovoRapid® FlexTouch® have the option to transition to the Penfill® format with NovoPen® 4, our durable insulin device that is available free-of-charge for patients at the pharmacy.
Health Canada comments
Tier 3 Status No
Contact Address 101-2476 ARGENTIA ROAD
MISSISSAUGA, ONTARIO
CANADA L5N 6M1
Company contact information 1 800 465 4334

Version History

Click on "Compare" below to view the full report history and compare to other versions.

Version Number Date Updated Language
v19 2023-08-17 English Compare
v18 2023-08-16 French Compare
v17 2023-08-16 English Compare
v16 2023-08-07 French Compare
v15 2023-08-07 English Compare
v14 2023-07-06 French Compare
v13 2023-07-06 English Compare
v12 2023-02-01 French Compare
v11 2023-02-01 French Compare
v10 2023-02-01 English Compare
v9 2023-02-01 French Compare
v8 2023-02-01 English Compare
v7 2023-02-01 French Compare
v6 2023-02-01 English Compare
v5 2023-02-01 French Compare
v4 2023-02-01 English Compare
v3 2023-02-01 French Compare
v2 2023-02-01 English Compare
v1 2023-02-01 English Compare

Showing 1 to 19 of 19